<SEC-DOCUMENT>0001333493-25-000065.txt : 20250602
<SEC-HEADER>0001333493-25-000065.hdr.sgml : 20250602
<ACCEPTANCE-DATETIME>20250602161925
ACCESSION NUMBER:		0001333493-25-000065
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250602
DATE AS OF CHANGE:		20250602

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			eHealth, Inc.
		CENTRAL INDEX KEY:			0001333493
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE AGENTS BROKERS & SERVICES [6411]
		ORGANIZATION NAME:           	02 Finance
		EIN:				770470789
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33071
		FILM NUMBER:		251015214

	BUSINESS ADDRESS:	
		STREET 1:		13620 RANCH ROAD 620 N, SUITE A250
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78717
		BUSINESS PHONE:		737-248-2340

	MAIL ADDRESS:	
		STREET 1:		13620 RANCH ROAD 620 N, SUITE A250
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78717
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>defa14aceoletter2025.htm
<DESCRIPTION>DEFA14A
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="id0243e8d99cc41afb4bf0fd7000e0102_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________________________&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SCHEDULE 14A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section&#160;14(a) of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the Securities Exchange Act of 1934</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;____________________________&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.75pt"><tr><td style="width:1.0pt"></td><td style="width:96.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:169.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:169.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Filed by the Registrant</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Filed by a party other than the Registrant</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Check the appropriate box&#58;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Confidential, For Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2))</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Definitive Proxy Statement</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Definitive Additional Materials</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Soliciting Material under &#167;&#160;240.14a-12</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">EHEALTH, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Name of Registrant as Specified in Its Charter)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Name of Person(s) Filing Proxy Statement, if Other than the Registrant)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payment of Filing Fee (Check all boxes that apply)&#58;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.471%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">No fee required.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials.</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id0243e8d99cc41afb4bf0fd7000e0102_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><img alt="ehealthlogoa.jpg" src="ehealthlogoa.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:119px"></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 2, 2025</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Letter from our CEO</font></div><div><font><br></font></div><div><font style="color:#0c6e1e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dear Fellow Stockholder&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I am writing to you to seek your support of our proposal to approve an amendment and restatement of the 2024 Equity Incentive Plan (as amended and restated, the &#8220;2024 Amended Equity Plan&#8221;) to increase the maximum number of shares of common stock that may be issued thereunder by 1,500,000 shares. The passing of this proposal is critical to our successful strategy execution as we navigate a highly dynamic Medicare industry environment and build upon significant operational achievements of 2024. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024 eHealth delivered outstanding execution during the Medicare Annual Enrollment Period, materially exceeding our expectations for enrollment volumes, revenue, and earnings. Fourth quarter revenue grew 27% compared to a year ago. Over the same period, Medicare submissions grew 38%, with our agency model growing submissions by 49% &#8211; well above the overall Medicare market. We delivered this growth while substantially improving our enrollment margins. This is a testament to the success of the transformed eHealth, including the exceptional performance of our employees and this leadership team.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024 also marked our return to profitability on a GAAP net income basis &#8211; a substantial achievement and indicator of the progress this organization has made over the past three years. 2024 annual revenue of $532.4 million increased 18%. 2024 GAAP net income was $10.1 million, an increase of $38.3 million or 136%, and net income (loss) margin improved to positive 2% from negative 2% year-over-year. Adjusted EBITDA was $69.3 million, an increase of $55.2 million or over 390%, and adjusted EBITDA margin was 13% for the year &#8211; a material improvement compared to a 3% margin a year ago. We maintained this momentum into the first quarter of 2025, delivering another quarter of strong enrollment and revenue growth, while also enhancing Medicare enrollment margins and increasing overall profitability compared to Q1 of 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With these results, we are on track to deliver on the three-year revenue and adjusted EBITDA targets that we provided to our investors last year. These targets included our goal to grow at an 8-10% revenue CAGR between 2023 and 2026 and to reach 8-10% adjusted EBITDA margin by 2026. Based on the mid-points of our 2025 annual guidance ranges, our 2023-2025 revenue CAGR is expected to be 8% with an implied 2025 adjusted EBITDA margin of 9%. It also implies an impressive 2023-2025 adjusted EBITDA CAGR of 84%.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicare industry environment remains highly dynamic and volatile with multiple macro, regulatory and competitive factors impacting our execution. We remain confident in our ability to succeed in this environment through our opportunistic, flexible approach to strategic and operational decisions. Being able to retain and incentivize our high-performing employees will be especially critical to our ability to deliver on financial targets while maintaining full alignment of our employee and stockholder interests.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly engage with our investors and take their inputs on our compensation practices and broader corporate governance issues very seriously.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the feedback we received over the past two years, we have shifted a greater percentage of our equity compensation towards performance-based equity awards and set multi-year performance targets to help achieve even greater alignment between our strategic goals and compensation. As outlined in our definitive proxy statement filed on April 28, 2025, annual equity awards in the form of performance-based awards represented 50% and 35% of total annual 2024 equity grants to the CEO and Named Executive Officers, respectively, compared to 42% and 25% in 2023. In 2025, our current plan is to grant at least 50% of our annual equity incentive awards to our Named Executive Officers in the form of performance-based awards with metrics measured over a three-year period compared to a two-year measurement period for our 2024 grants.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024 we also reduced both the burn rates and the amount of total stock-based compensation despite achieving significant revenue and profitability growth compared to 2023.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2024 gross burn rate was 7.8% compared to 9.8% in 2023, and our 2024 net burn rate was 5.7% compared to 8.4% in 2023 (see </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id0243e8d99cc41afb4bf0fd7000e0102_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 1</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our 2024 total stock-based compensation was $19.9 million compared to $23.2 million in 2023. As seen in </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id0243e8d99cc41afb4bf0fd7000e0102_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 2</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the mid-point of our 2025 annual guidance implies another year-over-year reduction in stock-based compensation in 2025.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ISS Data&#58; It is important to note that ISS compares eHealth to the appropriate peer group for the purpose of evaluating our executive compensation. However, when evaluating our equity plan, ISS uses a different set of peer group companies consisting of firms in our GICS industry group &#8211; typically regional financial services companies. These companies do not compete for the same talent pool as eHealth and are subject to different compensation practices including typically providing equity-based compensation only to a handful of top executives. In contrast, companies in healthcare technology and insuretech industries where eHealth competes for talent, grant equity to a substantially broader base of employees. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In sum, we believe the 2024 Amended Equity Plan is an important factor in attracting, retaining and rewarding high caliber employees who are essential to our success and in providing incentives to these individuals for achieving critical operational and financial goals. eHealth is also currently in the process of searching for the new Chief Executive Officer to succeed me, following my announcement of retirement plans last year.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity will be an important part of attracting a strong candidate who will be taking over the transformed eHealth to continue scaling our core business and advancing diversification plans with an ultimate goal of achieving sustainable cash flow generation and building shareholder value. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without additional shares available for issuance under an equity incentive plan, we would likely be compelled to increase the cash component of employee and incoming Chief Executive Officer compensation to remain competitive, which runs directly counter to our core objective of maximizing cash flow generation. Our Board of Directors unanimously recommends that you vote &#8220;</font><font style="color:#dc188e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; the approval of </font><font style="color:#dc188e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Proposal 4 </font><font style="background-color:#ffffff;color:#dc188e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;</font><font style="color:#dc188e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> an amendment and restatement of the eHealth, Inc. 2024 Equity Incentive Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Thank you for your consideration and anticipated support.</font></div><div style="margin-bottom:6pt;margin-top:17pt;text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:159.00pt"><tr><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:154.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sincerely yours,</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:48pt"><td colspan="6" style="padding:0 1pt"><div style="text-align:justify"><img alt="franssiga.jpg" src="franssiga.jpg" style="height:58px;margin-bottom:5pt;vertical-align:text-bottom;width:163px"></div></td></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Francis S. Soistman</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Director</font></div></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:198pt"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Gross burn rate was calculated as the total of equity awards granted during the fiscal year, divided by the weighted average number of shares outstanding. Net burn rate was calculated as equity awards granted during the fiscal year less equity awards cancelled and returned to the plan, divided by the weighted average number of shares outstanding.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id0243e8d99cc41afb4bf0fd7000e0102_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Forward-Looking Statements</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">This letter to our stockholders from our Chief Executive Officer contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding our expectations regarding our business, operations, strategy and long-term vision&#59; competition in our industry, market trends and our expectations and predictions for our industry&#59; our financial prospects and outlook&#59; future stockholder value&#59; expected growth and value creation&#59; the expected impact of adding additional shares to our equity plan on our ability to hire and retain our workforce&#59; our expected equity burn rate in 2025&#59; our expected priorities and performance&#59; our financial targets, including our three-year financial targets for revenue growth, adjusted EBITDA margin and adjusted EBITDA growth, and our ability to achieve our financial targets&#59; our 2025 annual guidance for total revenue, GAAP net income (loss) and adjusted EBITDA&#59; our expectations regarding Chief Executive Officer transition&#59; the effectiveness and impact of our senior leadership and workforce&#59; and other statements regarding our future operations, financial condition, prospects and business strategies. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">These forward-looking statements are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made, including the risks and uncertainties described in our most recent Quarterly Report on Form 10-Q or Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and available on the Investor Relations page of our website at ir.ehealthinsurance.com and on the Securities and Exchange Commission&#8217;s website at www.sec.gov. In particular, we are required by Accounting Standards Codification 606 &#8212; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:105%">Revenue from Contracts with Customers</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%"> to make numerous assumptions that are based on historical trends and our management&#8217;s judgment. These assumptions may change over time and have a material impact on our revenue recognition, guidance, and results of operations. Please review the assumptions stated in this communication carefully. All forward-looking statements in this letter are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Non-GAAP Information</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">This letter to our stockholders from our Chief Executive Officer includes adjusted EBITDA and adjusted EBITDA margin, non-GAAP financial measures. Adjusted EBITDA is calculated by excluding dividends for preferred stock and change in preferred stock redemption value (together the &#8220;impact from preferred stock&#8221;), provision for (benefit from) income taxes, depreciation and amortization, stock-based compensation expense, impairment, restructuring and other charges, interest expense, other income (expense), net, and other non-recurring charges from GAAP net income (loss) attributable to common stockholders. Other non-recurring charges to GAAP net income (loss) attributable to common stockholders may include transaction expenses in connection with capital raising transactions (whether debt, equity or equity-linked) and acquisitions, whether or not consummated, purchase price adjustments and the cumulative effect of a change in accounting principles. Adjusted EBITDA margin is calculated as adjusted EBITDA divided by total revenue.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The presentation of non-GAAP financial information is not intended to be considered in isolation or as a substitute for results prepared in accordance with GAAP. A reconciliation of adjusted EBITDA and adjusted EBITDA margin to GAAP net income (loss) attributable to common stockholders, the most directly comparable GAAP financial measure, is available in </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="#id0243e8d99cc41afb4bf0fd7000e0102_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit 2</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. Management uses both GAAP and non-GAAP information in evaluating and operating its business internally and as such has determined that it is important to provide this information to investors.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Additional Information and Where to Find It</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">eHealth has filed with the SEC a definitive proxy statement on Schedule 14A, with respect to its solicitation of proxies for eHealth&#8217;s 2025 Annual Meeting of Stockholders. Investors and stockholders are urged to read the proxy statement (including any amendments or supplements thereto) filed with the SEC carefully and in their entirety because they contain or will contain important information about any solicitation. Investors and stockholders may obtain copies of these documents and other documents filed with the SEC by eHealth free of charge at www.proxyvote.com. Copies of the documents filed by eHealth are also available on the Investor Relations page of our website at ir.ehealthinsurance.com and on the Securities and Exchange Commission&#8217;s website at www.sec.gov.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id0243e8d99cc41afb4bf0fd7000e0102_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Exhibit 1</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:115%">Our Gross Burn Rate vs. Net Burn Rate</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:62.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.452%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.453%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#0f7f40;border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#0f7f40;border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="background-color:#0f7f40;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#0f7f40;border-right:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Full-Value Shares (FVS) Granted</font></div></td><td colspan="2" style="background-color:#dbdbdb;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,286,000&#160;</font></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,750,000&#160;</font></td><td style="background-color:#dbdbdb;border-right:1pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Common Shares Outstanding</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,335,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,016,000&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Burn Rate</font></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7.8%</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.8%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Cancelled&#47;Forfeited Grants</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cancelled&#47;Forfeited Options</font></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</font></td><td style="background-color:#dbdbdb;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cancelled&#47;Forfeited FVS</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">608,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">387,000&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Options Granted</font></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,000)</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,000)</font></td><td style="background-color:#dbdbdb;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net FVS Granted</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,678,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,363,000&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Common Shares Outstanding</font></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,335,000&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,016,000&#160;</font></td><td style="background-color:#dbdbdb;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Burn Rate</font></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.7%</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.4%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id0243e8d99cc41afb4bf0fd7000e0102_22"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Exhibit 2</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:115%">Reconciliation of GAAP to Non-GAAP Financial Measures</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Reconciliation of GAAP Net Loss Attributable to Common Stockholders to Adjusted EBITDA (in millions) and Adjusted EBITDA Margin&#58;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:62.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.567%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#0f7f40;border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#0f7f40;border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </font></td></tr><tr><td colspan="3" style="background-color:#0f7f40;border-left:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#0f7f40;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="background-color:#0f7f40;padding:0 1pt"></td><td colspan="3" style="background-color:#0f7f40;border-right:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GAAP net loss attributable to common stockholders</font></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35.0)</font></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66.5)</font></td><td style="background-color:#ffffff;border-right:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</font></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.2&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</font></td><td style="background-color:#dbdbdb;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in preferred stock redemption value</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.3&#160;</font></td><td style="background-color:#ffffff;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GAAP net income (loss)</font></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.2)</font></td><td style="background-color:#dbdbdb;border-right:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</font></td><td style="background-color:#ffffff;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.3&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.9&#160;</font></td><td style="background-color:#dbdbdb;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment, restructuring and other charges</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.2&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</font></td><td style="background-color:#dbdbdb;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.5)</font></td><td style="background-color:#ffffff;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</font></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.3&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</font></td><td style="background-color:#dbdbdb;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.1&#160;</font></td><td style="background-color:#ffffff;border-right:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GAAP Net income (loss) margin</font></div></td><td colspan="3" style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-right:1.5pt solid #000;border-top:3pt double #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA margin</font></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13%</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1.5pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Reconciliation of Guidance GAAP Net Loss Attributable to Common Stockholders to Adjusted EBITDA (in millions) and Adjusted EBITDA Margin&#58;</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:62.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.452%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#0f7f40;border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#0f7f40;border-right:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Full Year 2025 Guidance</font></td></tr><tr><td colspan="3" style="background-color:#0f7f40;border-left:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#0f7f40;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low</font></td><td colspan="3" style="background-color:#0f7f40;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#0f7f40;border-right:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GAAP net loss attributable to common stockholders</font></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60.0)</font></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#dbdbdb;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35.0)</font></td><td style="background-color:#dbdbdb;border-right:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact from preferred stock</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.0&#160;</font></td><td style="background-color:#ffffff;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GAAP net income (loss)</font></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.0)</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</font></td><td style="background-color:#dbdbdb;border-right:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</font></td><td style="background-color:#ffffff;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0&#160;</font></td><td style="background-color:#dbdbdb;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0&#160;</font></td><td style="background-color:#ffffff;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</font></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</font></td><td style="background-color:#dbdbdb;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.0&#160;</font></td><td style="background-color:#ffffff;border-right:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.0&#160;</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.0&#160;</font></td><td style="background-color:#dbdbdb;border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GAAP Net income (loss) margin</font></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1.5pt solid #000;border-top:3pt double #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3%</font></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1.5pt solid #000;border-left:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA margin</font></div></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1.5pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7%</font></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1.5pt solid #000;border-right:1.5pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11%</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ehealthlogoa.jpg
<TEXT>
begin 644 ehealthlogoa.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !" ,T# 2(  A$! Q$!_\0
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M;:-+:W-QJ\-PT<%LZ1*QE4G&<X'7OWKB_P#@IU_R6?PW_P!@%/\ THGKZ]^
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MI1QD%AUS8R46E;EY?P[6.4_8$T;Q)H/[2&E/)I6H6-E<V5W#=236SHGE^47
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M\% _"OF3_@J%_P E$\&?]@J3_P!'&OI_]A'_ )-3\#_]OW_I=<4J7^]3]/\
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D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>franssiga.jpg
<TEXT>
begin 644 franssiga.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "* 7X# 2(  A$! Q$!_\0
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MY"_W;O41Q/<D>B]!^%?7E PHHHH$%%%% !1110 4444 %%%% !1110 4444
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MC> ?#=AX?\/Z=#I6CV,0AM[2W7"HH_F?<\FMB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!\G:F4^3M3* "BBB@
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( (J*EHH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
